Orabloc 1:100,000 0.018 mg (Epinephrine Bitartrate SOLUTION) 0.018 MG

ORABLOC 1:100,000 0.018 MG is a solution containing epinephrine bitartrate, used for local anesthesia. It is designed for block or infiltration procedures, providing effective pain relief.

Strength

0.018 MG

Pack Size

1.7ML

Manufacturer / TM Owner

PIERREL S.P.A.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ORABLOC 1:100,000 0.018 MG is primarily used in dental and medical procedures to provide local anesthesia. It helps to numb the area, making it easier to perform various treatments. This solution is often used for what is epinephrine bitartrate used for, including pain relief during dental work or minor surgical procedures.

Side Effects

When administered, ORABLOC 1:100,000 0.018 MG may cause temporary numbness and reduced sensation in the treated area. Some individuals might experience common effects such as mild swelling or redness at the injection site. These effects are usually short-lived and subside quickly.

Precautions & Warnings

It is important to handle ORABLOC 1:100,000 0.018 MG with care and follow the instructions provided by a healthcare professional. Always ensure the solution is stored properly and used within its expiration date. Avoid using this product if you have known allergies to any of its components.

Avoid Interactions

ORABLOC 1:100,000 0.018 MG may interact with certain medications, including other anesthetics and blood pressure drugs. It is advisable to inform your healthcare provider about all medications you are taking before using this solution. Additionally, avoid consuming alcohol while using this product.

Frequently Asked Questions

ORABLOC 1:100,000 0.018 MG is used for local anesthesia in dental and medical procedures to provide pain relief.

ORABLOC 1:100,000 0.018 MG should be stored as per the manufacturer's instructions, typically at room temperature and away from direct sunlight.

Common side effects may include temporary numbness, mild swelling, or redness at the injection site.

It is important to consult a healthcare professional before using ORABLOC 1:100,000 0.018 MG with other medications to avoid potential interactions.

ORABLOC 1:100,000 0.018 MG should not be used by individuals with known allergies to its components. Always consult a healthcare professional for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.